FDA NDC Directory · JSON-LD · Markdown

Theophylline

NDC 62332-026 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerAlembic Pharmaceuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA090430
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsTHEOPHYLLINE ANHYDROUS (450 mg/1)
Marketing started20160129
Package count3

External sources

Source: openFDA. Public-domain (CC0).